Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer
This is a non-interventional study，aim to observe the safety and efficiency of different treatment regimen for peritoneal metastasis of Stage IV gastric cancer in the real world
Stage IV Gastric Cancer With Metastasis
DRUG: S-1|DRUG: oxaliplatin|DEVICE: Hyperthermic Intraperitoneal|DRUG: Paclitaxel
PFS: Progression Free Survival, time from enrollment to disease progression or death, through study completion, an average of 1 year
OS:overall survival, time from enrollment to death, 3 years|Safety, measured by recording the subjects' Adverse Events according to CTCAE 4.03, 3 years
This is a non-interventional study，aim to observe the safety and efficiency of different treatment regimen for peritoneal metastasis of Stage IV gastric cancer in the real world